Regeneron to make mAb Ebola drug for trials with BARDA backing
Regeneron Pharmaceuticals will use it speedy mAb development tech to move an Ebola drug into clinical trials under a $38m (€34m) US Government contract.
Archives for September 22, 2015
Vaccine-maker IDT Biologika launches in US
German CDMO IDT Biologika has opened its first facility in the US and will contract manufacture vaccines.
EC, EU and WHO share 'need to know' private drug data
European regulators and the WHO have begun sharing confidential information about drug applications, quality, and inspections under a new agreement.